Warmed Blood Transfusion in Premature Infants
Launched by GOZTEPE PROF DR SULEYMAN YALCIN CITY HOSPITAL · May 21, 2024
Trial Information
Current as of February 19, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This trial is planned to be randomized and controlled. Erythrocyte transfusion (ET) will be applied to premature babies born below the 34th gestational week, based on the limit values specified by TND, during Level 3 routine intensive care treatment and follow-up. They will be divided into two groups of 20 babies each: control and study groups. The control group will receive erythrocyte transfusion without heating, which is routinely applied. Heated ET will be performed on the study group by physiological warming between 34-36C⁰.
Procedures to be applied for the working group:
1. ET requi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Premature babies less than 34 weeks of gestation Babies requiring ES transfusions while receiving treatment in the NICU
- Exclusion Criteria:
- • babies with severe congenital anomalies
Trial Officials
Fahri Ovalı, Prof
Study Chair
Istanbul Medeniyet University
About Goztepe Prof Dr Suleyman Yalcın City Hospital
Goztepe Prof. Dr. Suleyman Yalcın City Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Renowned for its state-of-the-art facilities and multidisciplinary approach, the hospital focuses on a wide range of therapeutic areas, fostering collaboration among healthcare professionals to ensure high standards of care and ethical research practices. Committed to enhancing medical knowledge, Goztepe City Hospital plays a pivotal role in bringing groundbreaking treatments to the forefront of clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, N/A (N/A), Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0